Abstract
Methotrexate (MTX) is a widely used chemotherapeutic and immunosuppressive drug that requires precise monitoring due to its narrow therapeutic index and potential toxicity. Recent advancements in nanomaterial-based electrochemical sensors have significantly improved detection limits, selectivity, and stability by incorporating metal nanoparticles, graphene-based composites, metal oxides, and conductive polymers. This review critically discusses the latest progress in nanomaterial-based sensors for MTX detection, with an emphasis on sensor fabrication strategies, electrode modifications, and signal enhancement signals [low detection limit (0.627 nM) and high sensitivity (13.2 μAM −1 cm −2 )]. Finally, we provide insights into future perspectives, including the integration of artificial intelligence, flexible sensor platforms, and wearable technologies for real-time monitoring of MTX. This comprehensive overview aims to guide researchers in developing next-generation electrochemical sensors for clinical and pharmaceutical applications.

This publication has 179 references indexed in Scilit: